…1;372(6547):eaba2609.Ethics Approval This study was approved by Queen’s University Human Subjects Research Ethics Board (HSREB# ONGY-600-21).Abstract 64 Figure 1Determining tolerance …
All extracted funders
Showing 961–1,020 of 3,238, ordered by supporting articles. Choose a funder to see its evidence.
Articles mentioning funders
5,089 articles · page 333 of 425…Surrey’s Animal Welfare and Ethical Review Body, as well as the UK Home Office under project licence number PP7099312.…
…ics 2024;32:593–613.Acknowledgements This work was supported by NIH DP5OD031846 and T32CA009109, DOD BCRP Era of Hope Scholar Award, Wallace H.…
…nvestigated whether targeting glycolysis using pramlintide,7 an FDA approved amylin analogue for type II Diabetes, can suppress EWS…
…al Care Committee (CIPA) and carried out in compliance with the Canadian Council at the CRCHUM.…
…vaccines.Methods Two small molecule inhibitors, TT-10 and TT-4 (Portage Biotech) targeting type A2A and A2B receptors, respectively, expressed …
….jconrel.2021.01.023Acknowledgements This work was supported by NIH DP5OD031846 and R21CA292273; U.S. DoD CDMRP Peer-Reviewed Cancer Research P…
…munotherapy response.Acknowledgements We gratefully acknowledge Immunomedics/Gilead for the gift of hRS7. We thank Grace Dejun Wu, Akiko Suzuki, Da…
…munotherapy.Ethics Approval Animal studies were approved by the IACUC #2019-0042.…
… and on treatment PBMC samples (n=54) from patients enrolled in NCT03366844, and performed single cell RNA sequencing(scRNAseq), single cel…
…s 2023;115;48–59.Ethics Approval This study was approved by the NIH institutional IACUC; study number protocol POB-003-2-B.Abstract 675 Figure 1[67Cu]C…
…21002, B.P.), the Australian National Breast Cancer Foundation (NBCF, IIRS-23-016), and Tour de Cure (RSP-239-FY2023).References Onk…